HIGHLIGHTS
- who: Nicola Hermann et al. from the Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland have published the research: Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study, in the Journal: (JOURNAL)
- what: The aim of this study was to explore clinical biological and prognostic features of melanoma patients with VLD under CPI-treatment and to explore whether they exhibit characteristic immune response profile in peripheral blood. Responsiveness to Immunotherapy (stained with anti-Melan-A, -SOX-10, andresponsiveness -tyrosinase antibodies) were completely absent Next, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.